A pilot/phase II study of gemcitabine (G) and split dose cisplatin (C) in advanced or metastatic non-small cell lung cancer (NSCLC) in an outpatient setting
2005 ◽
Vol 23
(16_suppl)
◽
pp. 7272-7272
Keyword(s):
Phase Ii
◽